Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Rani Therapeutics prices $20M direct offering of Class A common stock at market price

Company Fundamentals
26 May 2026
Na
View Source
Bullish
pluang ai news

Rani Therapeutics Holdings, a clinical-stage biotherapeutics company, announced a registered direct offering of Class A common stock priced at-the-market under Nasdaq rules. The offering includes 12.48 million shares and pre-funded warrants for 6.21 million shares, priced around $1.07 each, led by a sovereign wealth fund and healthcare-focused investors. The gross proceeds are expected to be approximately $20 million, which will support Rani's development of its oral biologics delivery technology, including the RaniPill®. The offering is expected to close around May 27, 2026, subject to customary conditions.

More News

Baker Hughes extends and expands well construction contract with Petrobras in Brazil's Santos Basin.

Baker Hughes extends and expands well construction contract with Petrobras in Brazil's Santos Basin.

Baker Hughes has extended and expanded its contract with Petrobras to provide integrated well construction solutions in Brazil's Santos Basin. The company will deploy advanced technologies like the AutoTrak rotary steerable system and Dynamus drill b...

Market News
Bullish
1 hour ago
California Resources achieves first CO₂ injection at Carbon TerraVault I, advancing California's carbon capture efforts.

California Resources achieves first CO₂ injection at Carbon TerraVault I, advancing California's carbon capture efforts.

California Resources Corporation has completed the first CO₂ injection at Carbon TerraVault I, California's first operational carbon capture and storage (CCS) project located in Kern County. This milestone marks a significant step toward California's...

Market News
Bullish
1 hour ago
REalloys advances heavy rare earth supply chain with $20.6M investment in Canadian processing upgrades.

REalloys advances heavy rare earth supply chain with $20.6M investment in Canadian processing upgrades.

REalloys Inc. has committed $20.6 million to upgrade the Saskatchewan Research Council's rare earth processing facility, increasing production capacity for critical rare earth metals like Neodymium-Praseodymium, Dysprosium, and Terbium. These upgrade...

Market News
Bullish
1 hour ago
Cartesian Therapeutics secures $150M non-dilutive financing, advancing CAR-T trials with key data expected in 2027.

Cartesian Therapeutics secures $150M non-dilutive financing, advancing CAR-T trials with key data expected in 2027.

Cartesian Therapeutics secured up to $150 million in non-dilutive financing from K2 HealthVentures, with an initial $50 million tranche extending its cash runway into 2028. This funding supports the advancement of multiple clinical trials for its CAR...

Company Fundamentals
Bullish
1 hour ago
Rocket Lab stock rises on strong Q1 results and new $90M Space Force satellite contract.

Rocket Lab stock rises on strong Q1 results and new $90M Space Force satellite contract.

Rocket Lab's stock surged following strong Q1 2026 results, with revenue up 63.5% year-over-year to $200.3 million and a record backlog of $2.2 billion. The company also secured a $90 million contract from the U.S. Space Force to design and manufactu...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App